Related references
Note: Only part of the references are listed.Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design
Rainer Wessely et al.
EUROPEAN HEART JOURNAL (2007)
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease
Albert Schoemig et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Drug eluting stents: an updated meta-analysis of randomised controlled trials
C Roiron et al.
HEART (2006)
Hypersensitivity cases associated with drug-eluting coronary stents - A review of available cases from the research on adverse drug events and reports (RADAR) project
JR Nebeker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent
R Wessely et al.
ANNALS OF INTERNAL MEDICINE (2005)
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients
A Dibra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization
S Windecker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease -: Meta-analysis of randomized trials
A Kastrati et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
FASTTRACK -: Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymerfree, on-site stent coating
J Hausleiter et al.
EUROPEAN HEART JOURNAL (2005)
Influence of stent surface topography on the outcomes of patients undergoing coronary stenting:: A randomized double-blind controlled trial
A Dibra et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2005)
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
I Iakovou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating
R Wessely et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel
AD Levin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
JW Moses et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
M Morice et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
